![](/img/cover-not-exists.png)
The advantages and risks of ruxolitinib for the treatment of polycythemia vera
Colafigli, Gioia, Scalzulli, Emilia, Pepe, Sara, Di Prima, Alessio, Efficace, Fabio, Martelli, Maurizio, Foà , Robin, Breccia, MassimoJournal:
Expert Review of Hematology
DOI:
10.1080/17474086.2020.1816819
Date:
September, 2020
File:
PDF, 701 KB
2020